The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1267 articles
Research indicates that GLP-1 therapies offer enhanced weight benefits compared to metformin in adolescents diagnosed with type 2 diabetes. The study highlights comparable glycemic control with GLP-1 drugs but superior weight reduction.
New research indicates that semaglutide and tirzepatide, drugs used for managing type 2 diabetes, exhibit heart-protective effects in real-world settings, mirroring findings from clinical trials. The study highlights the cardiovascular benefits these medications offer to patients in everyday clinical practice.
Novo Nordisk India and Emcure Pharma have announced a strategic partnership to launch Poviztra®, a semaglutide injection, in India. This collaboration aims to improve the availability and marketing of semaglutide for weight management across the country.
Stylist Tan France is collaborating with Lilly, the makers of Zepbound, on the 'Changing the Thread Collection,' a clothing line designed to share stories and science related to obesity. The collection aims to challenge societal biases and promote understanding of obesity as a chronic disease.
Gordon Ramsay is standing firm against modifying restaurant menus to accommodate individuals using weight-loss drugs like Ozempic. The celebrity chef believes overeating is a personal responsibility, not a restaurant's obligation. He advocates for mindful eating and discipline.
Actress Tamannaah Bhatia has spoken out about rumors surrounding her weight and addressed her struggles with inflammation. She emphasized the changing nature of a woman's body and the importance of embracing natural curves.
A recent report highlights the states with the highest obesity rates and analyzes the increasing use of GLP-1 medications such as Ozempic. The data reveals regional trends and potential impacts on public health, with higher usage in the South, Midwest, and Appalachia.
As the effects of weight loss medications like Mounjaro or Wegovy potentially diminish, some may be tempted to explore social media tricks. Discover scientifically-informed strategies to enhance your weight loss journey and overcome plateaus.
Scientists are exploring a way to enable the body's own production of glucagon-like peptide-1 (GLP-1), the hormone mimicked by weight-loss drugs. Two biotech startups are developing gene therapies to reprogram cells to produce GLP-1, potentially replacing regular injections.
